163 related articles for article (PubMed ID: 17596568)
1. MDS researchers seek treatments but find few.
Bankhead C
J Natl Cancer Inst; 2007 Jul; 99(13):996-7. PubMed ID: 17596568
[No Abstract] [Full Text] [Related]
2. Advances in stem cell transplantation: making it better and safer.
Giralt S
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S293-5. PubMed ID: 19778855
[TBL] [Abstract][Full Text] [Related]
3. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
Sill H; Zinke-Cerwenka W; Berghold A
Bone Marrow Transplant; 2007 Apr; 39(8):509; author reply 509-10. PubMed ID: 17322936
[No Abstract] [Full Text] [Related]
4. What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
Deeg HJ
Leuk Res; 2004 Jun; 28(6):543-4. PubMed ID: 15120927
[No Abstract] [Full Text] [Related]
5. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
[TBL] [Abstract][Full Text] [Related]
6. Update on the therapy for myelodysplastic syndrome.
Kasner MT; Luger SM
Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035
[TBL] [Abstract][Full Text] [Related]
7. [What to improve in approach to diagnose and treat pediatric myelodysplastic syndromes and juvenile myelomonocytic leukemia in Poland?].
Wójcik D; Pietras W; Ussowicz M; Chybicka A
Przegl Lek; 2006; 63(1):29-30. PubMed ID: 16892896
[TBL] [Abstract][Full Text] [Related]
8. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Oliansky DM; Antin JH; Bennett JM; Deeg HJ; Engelhardt C; Heptinstall KV; de Lima M; Gore SD; Potts RG; Silverman LR; Jones RB; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2009 Feb; 15(2):137-72. PubMed ID: 19167676
[TBL] [Abstract][Full Text] [Related]
9. The evolving clinical scenario of myelodysplastic syndrome: the need for a complete and up to date upfront diagnostic assessment.
Pilo F; Di Tucci AA; Dessalvi P; Caddori A; Angelucci E
Eur J Intern Med; 2010 Dec; 21(6):490-5. PubMed ID: 21111932
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Ferretti G; Papaldo P
Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
[No Abstract] [Full Text] [Related]
11. Outcome of patients who develop acute leukemia or myelodysplasia as a second malignancy after solid tumors treated surgically or with strategies that include chemotherapy and/or radiation.
Abdelhameed A; Pond GR; Mitsakakis N; Brandwein J; Chun K; Gupta V; Kamel-Reid S; Lipton JH; Minden MD; Schimmer A; Schuh A; Yee K; Messner HA
Cancer; 2008 Apr; 112(7):1513-21. PubMed ID: 18286528
[TBL] [Abstract][Full Text] [Related]
12. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
[TBL] [Abstract][Full Text] [Related]
13. Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and acute myelogenous leukemia.
Valcárcel D; Martino R
Curr Opin Oncol; 2007 Nov; 19(6):660-6. PubMed ID: 17906468
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fey MF; Dreyling M;
Ann Oncol; 2010 May; 21 Suppl 5():v158-61. PubMed ID: 20555069
[No Abstract] [Full Text] [Related]
15. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
17. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.
Valent P; Horny HP; Bennett JM; Fonatsch C; Germing U; Greenberg P; Haferlach T; Haase D; Kolb HJ; Krieger O; Loken M; van de Loosdrecht A; Ogata K; Orfao A; Pfeilstöcker M; Rüter B; Sperr WR; Stauder R; Wells DA
Leuk Res; 2007 Jun; 31(6):727-36. PubMed ID: 17257673
[TBL] [Abstract][Full Text] [Related]
18. Autologous stem cell transplantation in myelodysplastic syndromes.
de Witte T; Suciu S; Brand R; Muus P; Kröger N
Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
[TBL] [Abstract][Full Text] [Related]
19. Impact on survival of different treatments for myelodysplastic syndromes (MDS).
Nachtkamp K; Kündgen A; Strupp C; Giagounidis A; Kobbe G; Gattermann N; Haas R; Germing U
Leuk Res; 2009 Aug; 33(8):1024-8. PubMed ID: 19185917
[TBL] [Abstract][Full Text] [Related]
20. Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome.
Bernimoulin M; Stern M; Tichelli A; Jotterand M; Gratwohl A; Nissen C
Acta Haematol; 2008; 119(4):226-35. PubMed ID: 18566541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
